Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Allopregnanolone helps control oxytocin levels during pregnancy to prevent preterm labor.

Targeting PTEN can improve healing in venous leg ulcers.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

TAK-279 effectively reduces psoriasis symptoms and is safe.

SM04755 may be an effective topical treatment for psoriasis.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Astragalus extract may help with hair regrowth.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.